FundedIQ
Biotechnology

Biomarx: Funding, Investors & Team (Oct 2026)

Biomarx specializes in automated genomic diagnostics. The company develops rapid, low-cost liquid biopsy solutions to enable early lung cancer detection and replace traditional genome sequencing in clinical settings.

biomarx.co.uk LinkedIn Belfast, United Kingdom 1-10 employees
Biotechnology Health Diagnostics
Total raised
$940k
Rounds
1
Latest
Pre-Seed
Jan 2026

Biomarx has raised $940k across 1 funding round on record, the most recent a Pre-Seed of $940k announced in Jan 2026.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Biomarx Company Profile and Key Stats

Total funding raised
$940k
across 1 round on record
Funding rounds on record
1
Latest funding round
Pre-Seed
$940k in Jan 2026
Employees
1-10
reported band
Headquarters
Belfast, United Kingdom

Latest funding round on record: Jan 2026.

Biomarx Funding Rounds

Date
Round
Amount
Pre-Seed
$940k

Biomarx Founders and Leadership Team

Name
Role
Contact
Sean Macfarlane
Founder
Locked

Contact details for the Biomarx team: 1 of 1 has an email address on file.

Start 14-day free trial →

Biomarx Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
5,352
$4.1M
6,021
$600K

Biomarx's latest round of $940k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Biomarx in Biotechnology and Belfast

Companies Similar to Biomarx

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

Biomarx Funding FAQs

What does Biomarx do?

Biomarx specializes in automated genomic diagnostics. The company develops rapid, low-cost liquid biopsy solutions to enable early lung cancer detection and replace traditional genome sequencing in clinical settings.

How much funding has Biomarx raised?

Biomarx has raised $940k across 1 round on record. The most recent is a Pre-Seed of $940k announced in Jan 2026.

When did Biomarx last raise funding?

Biomarx's most recent funding round on record is a Pre-Seed of $940k, announced in Jan 2026.

Who founded Biomarx?

FundedIQ lists Sean Macfarlane (Founder) at Biomarx.

Where is Biomarx headquartered?

Biomarx is based in Belfast, Belfast, United Kingdom.

How many employees does Biomarx have?

Biomarx is in the 1-10 employee band.

How does Biomarx's funding compare to other Biotechnology startups?

Biomarx's latest round of $940k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Biomarx Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biomarx is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.